Case Study: Unveiling the Role of VIP in Refractory Graves’ Disease Patient: Sarah, a 35-year-old woman, diagnosed with Graves’ disease five years ago. Despite anti-thyroid medication (methimazole) and radioiodine ablation, she suffers from persistent hyperthyroidism, bulging eyes (exophthalmos), and debilitating fatigue. Challenge: Standard treatments haven’t achieved long-term remission. Sarah experiences side effects from methimazole, and...